INTRODUCTION
============

Osteoporotic vertebral fracture (OVF) is one of the most severe osteoporotic fractures, which causes severe pain, disability, dyspnea, deformity and raises the risk of subsequent fracture and death ([@B1][@B2]). Among the conservative treatments to OVF, multifarious orthoses are used and expected to immobilize the fracture site, diminish pain and improve quality of life. However, their authentic effectiveness to patients with OVF remains unclear ([@B1]). Several trials investigated the efficacy of orthoses, but quality of them varied a lot and their outcome parameters were not standardized. Conclusions from previously published systematic reviews had limited generalizability, due to their indirectness in participants or limited number of included studies ([@B3][@B4]). Additionally, strength of recommending orthoses to patients with OVF remained inconclusive in reviews or guidelines ([@B5][@B6]).

In order to explore the efficacy of orthoses, we conducted this study through a systematic literature search and meta-analysis. We focused on patients with osteoporotic vertebral fracture and analyzed the outcomes of pain, kyphosis angle and quality of life. Furthermore, we discussed the reasons why some orthoses were effective and some were not.

MATERIALS AND METHODS
=====================

Data source and searching strategy
----------------------------------

We searched electronic databases, including Medline, EMBASE, Central Register of Controlled Trials (CENTRAL) and Web of science, from May, 2015 and updated weekly until March, 2016. A search strategy included keywords of \"clinical trial\", \"osteoporotic fracture\", \"spine\", \"orthosis\", and \"brace\" was used. Details of the search strategy were presented in [Supplementary 1](#S1){ref-type="supplementary-material"}. Reference lists of other reviews were also checked for relevant articles.

Study selection
---------------

Initially, one author identified the potentially relevant articles by screening titles and abstracts, and then two authors evaluated their eligibility for being included in this study through full text assessment. The evaluation mainly focused on characteristics of the studies. English published articles that recruited participants who had at least one diagnosed OVF and implemented orthoses as interventions were included. Trials were excluded if they recruited subjects with traumatic vertebral fractures or pooled participants with and without fracture together but did not separately report their outcomes. Disagreements were solved by discussion between two authors.

Data extraction
---------------

We extracted information with standardized tables which described characteristics of participants, interventions and outcomes. Unclear information and data in studies was clarified by contacting their authors through e-mails. Outcomes of pain, kyphosis angle and quality of life (Oswestry disability index, Well-being and Functional independence measure-motor score) were statistically analyzed.

Methods used for extracting and handling data were slightly different according to studies. In studies reported outcomes at multiple time points, data from the last visit was extracted; in cross-over designed trials, data before the cross-over procedure was extracted. When synthesized the data from studies with 3 arms, the number of participants in control group was separated evenly, and each compared with one intervention group, with the value of mean and standard deviation (SD) unchanged.

Measurement of risk of bias
---------------------------

We assessed the quality of included randomized controlled trials (RCTs) with a method recommended by Cochrane back and neck group (CBN) ([@B7]). The method measured the risk of bias in 6 domains: selection, performance, detection, attribution, reporting and others.

Data synthesis and analysis
---------------------------

We pooled data using the Review Manager (Revman 5.3) and implemented the meta-analysis with the random effect model. Change value from baseline was used because most trials reported outcomes in that data type. If value of SD was not reported and needed to be estimated, the formula presented as follows was used, $$\text{SDchange} = \sqrt{\textit{SDbaseline}^{2} + \textit{SDfinal}^{2} - \left( {2 \times \textit{Corr} \times \mathit{S}\mathit{D}\text{baseline} \times \text{SDfinal}} \right)}$$

with an assignment of 0.5 as correlation value. The standardized mean difference (SMD) was used to synthesize the outcomes because the measuring scales were different between studies. Some mean values were multiplied by -1 to ensure results from different scales could point in the same direction. Expression of the magnitude of the results followed the rules of thumb (\< 0.2, small effect; 0.2 to 0.8, moderate effect; \> 0.8, large effect) ([@B8]). Statistical heterogeneity between studies was measured with the chi-squared test. The heterogeneity was considered as significant when *P* value was not bigger than 0.10 and was recognized as considerable when I^2^ value was bigger than 75% ([@B7]). To explore the heterogeneity, subgroup analysis was conducted. To prove our results were not depended on arbitrary decisions on including studies or assigning values, we conducted several sensitivity analyses. The analyses included estimating SD with the different correlation value (0.4), excluding some \"dubious\" articles and estimating results with the fixed effect model.

Measurement of quality of evidence
----------------------------------

To reflect our confidence in truthfulness of the results, we measured quality of evidence with the GRADE approach. The approach measures the limitations of results in 5 domains: study limitation (risk of bias), inconsistency, indirectness, imprecision and publication bias. Each item was downgraded 1 or 2 points if the result failed to meet the criteria ([@B9]). \"Study limitation\" was downgraded 1 point if 1 to 3 categories of risk of bias were rated as high or unclear. \"Inconsistency\" was downgraded 1 point if large statistical heterogeneity (*P* ≤ 0.10, I^2^ \> 80%) existed, downgraded 2 points if both large statistical heterogeneity and obvious clinical heterogeneity existed. \"Indirectness\" was downgraded 1 to 2 points if we detected indirectness in domains of population, intervention, comparator, comparison and outcome. \"Imprecision\" was downgraded 1 point if the total sample size was smaller than 400 and was downgraded 2 points if there were few events and wide confidence intervals (CIs). \"Publication bias\" was downgraded by 1 point only when we strongly suspected the existence of publication bias.

RESULTS
=======

Initially we identified 649 relevant citations and then remained 28 articles for full-text assessment. Eventually, 10 articles were included in this study ([@B10][@B11][@B12][@B13][@B14][@B15][@B16][@B17][@B18][@B19]) and 4 RCTs, with 281 participants, were included in meta-analysis ([@B10][@B11][@B12][@B14]) ([Fig. 1](#F1){ref-type="fig"}).

![Flow diagram of selection process.](jkms-31-1641-g001){#F1}

Description of included studies
-------------------------------

As summarized in [Table 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}, 6 RCTs ([@B10][@B11][@B12][@B13][@B14][@B15]), 1 non-randomized controlled trial ([@B19]) and 3 observational studies ([@B16][@B17][@B18]) were included. Characteristics of studies varied a lot but all had limited number of participants and only one trial had a sample size merely above 100 ([@B12]). Phase of fracture and recruiting sources of participants were different between studies. Participants had acute fractures in 3 trials ([@B10][@B14][@B18]) while those from another 3 trials had sub-acute fractures ([@B11][@B12][@B13]). Most of the studies recruited participants in hospital environment ([@B10][@B13][@B14][@B15][@B17][@B18][@B19]), while two trials recruited in community environment ([@B11][@B12]).

###### Characteristics of studies included in MA

![](jkms-31-1641-i001)

  Study ID                                                            Study design   Participants number   Phase of fracture   Participants source   Intervention                                                     Follow up duration
  ------------------------------------------------------------------- -------------- --------------------- ------------------- --------------------- ---------------------------------------------------------------- --------------------
  Kim et al. ([@B14]), 2014                                           RCT            60                    Acute               Hospital              Soft brace: 8 wk                                                 12 wk
  Rigid brace: 8 wk                                                                                                                                                                                                   
  Control group: no brace                                                                                                                                                                                             
  Li et al. ([@B10]), 2014                                            RCT            51                    Acute               Hospital              Group 1: TLSO, the1st week; SpinoMed, the 2nd and the 3rd week   3 wk
  Group 2: TLSO, the 1st week; Soft brace, the 2nd and the 3rd week                                                                                                                                                   
  Pfeifer et al. ([@B12]), 2011^\*^                                   RCT            108                   Subacute            Community             Group 1: Spinomed orthosis, 12 mon                               12 mon
  Group 2: Spinomed active orthosis, 12 mon                                                                                                                                                                           
  Group 3: no brace                                                                                                                                                                                                   
  Pfeifer et al. ([@B11]), 2004^\*^                                   RCT            62                    Subacute            Community             Group 1: Spinomed, 12 mon                                        12 mon
  Group 2: no brace                                                                                                                                                                                                   

MA, meta-analysis; RCT, randomized controlled trial; TLSO, thoracolumbar sacral orthosis.

^\*^This trial was designed as a cross-over study. We extracted the data before cross-over procedure, on the 6th month.

###### Characteristics of studies included in study but excluded from MA

![](jkms-31-1641-i002)

  Study ID                                                Study type                                                               Participants number   Phase of fracture   Participants source   Interventions                   Follow up duration   Conclusion
  ------------------------------------------------------- ------------------------------------------------------------------------ --------------------- ------------------- --------------------- ------------------------------- -------------------- ----------------------------------------------------------------------------------------------------------------
  Dionyssiots et al. ([@B13]), 2015^\*^                   RCT                                                                      50                    Subacute            Hospital              Group 1: Semi-rigid orthosis    6 mon                Wearing Spinomed orthosis decreased back pain significantly and increased trunk muscle strength significantly.
  Group 2: Elastic orthosis                                                                                                                                                                                                                             
  Group 3: Control group                                                                                                                                                                                                                                
  Sinaki and Lynn ([@B15]), 2002                          Pilot RCT                                                                7                     NA                  Hospital              Group 1: PTS + Exercise         1 mon                Subjects who had abnormal balance had the most significant improvement in balance.
  Group 2: Exercise                                                                                                                                                                                                                                     
  Valentin et al. ([@B16]), 2014                          Case series study                                                        13                    NA                  NA                    Spinomed III                    3 mon                The improvement in the back extensor strength was significant; but not in pain or physical function.
  Talic et al. ([@B19]), 2012                             N-RCT                                                                    59                    NA                  Hospital              Group 1: Three-point orthosis   1-4 mon              Plaster corset offered stability; but patients with orthoses were more mobile.
  Group 2: Plaster corset                                 Duration of immobilization was significantly longer in orthosis group.                                                                                                                        
  Murata et al. ([@B18]), 2012                            Retrospective study                                                      55                    Acute               Hospital              Plastic TLSO orthosis           6 mon                TLSO promoted the healing of OVF.
  Mean kyphosis angle deteriorated from 11.4° to 17.2°.                                                                                                                                                                                                 
  Liaw et al. ([@B17]), 2009                              Case series study                                                        47                    NA                  Hospital              Knight-Taylor orthosis          Immediately          Knight-Taylor brace improved in static and dynamic motor balance but decreased the directional control.

MA, meta-analysis; RCT, randomized controlled trial; PTS, posture training support; NA, not available; TLSO, thoracolumbar sacral orthosis; N-RCT, non-randomized controlled trial.

^\*^The data reported in this article was insufficient to be included in meta-analysis.

Most of the trials implemented semi-rigid brace (Spinomed orthosis) and rigid brace for middle to long term. Efficacy of the Spinomed orthosis was investigated in 4 RCTs ([@B10][@B11][@B12][@B13]) and 1 case series study ([@B16]). Three of the 4 RCTs were included in the meta-analysis ([@B10][@B11][@B12]) ([Table 1](#T1){ref-type="table"}), while Dionyssiotis et al.\'s study ([@B13]) was excluded due to their insufficiently reported data. Efficacy of rigid brace was investigated in 2 observational studies ([@B17][@B18]) and 2 controlled trials ([@B14][@B19]), one of which evaluated the efficacy of thoracolumbar sacral orthosis (TLSO) was included in meta-analysis ([@B14]) ([Table 1](#T1){ref-type="table"}). Implementation and follow-up periods ranged from 1 to 6 months in most studies, except one case series study that immediately measured effect of the Knight-Taylor brace after it was implemented ([@B17]).

Risk of bias of included RCTs
-----------------------------

All trials had high risk of bias in at least 1 category ([Fig. 2](#F2){ref-type="fig"}). Most trials had unclear risk of selection bias, due to their briefly reported procedures of random sequence generation and allocation concealment. All trials had high risk of performance bias because it was relatively difficult to maintain double blind while implemented braces. Risk of detection bias was evaluated separately in different outcomes, and only the measurement of the kyphosis angle was rated as low risk. Risk of attribution bias was rated as low in 4 trials ([@B11][@B12][@B14][@B15]). Risk of reporting bias was rated as unclear in half of the trials ([@B11][@B12][@B13]). Risk of other bias was evaluated as low in 5 trials that clarified no conflict of interest in conducting and publishing the researches ([@B10][@B11][@B12][@B13][@B14]). We presented the rationales for the judgements of risk of bias in [Supplementary 2](#S2){ref-type="supplementary-material"}.

![Risk of bias table of included randomized controlled trials. Green represents \"low risk of bias\"; yellow, \"unclear risk of bias\"; red, \"high risk of bias\".](jkms-31-1641-g002){#F2}

Effects of intervention: results from meta-analysis
---------------------------------------------------

Three studies investigated the efficacy of braces by comparing to no brace groups, including 230 participants ([@B11][@B12][@B14]). We analyzed the outcomes of pain, kyphosis angle and quality of life with subgroup analysis.

In the outcome of pain, the pooled data showed large and significant beneficial effect brought by using brace (SMD, -1.10; 95% CIs, -1.61 to -0.59; *P* \< 0.001, [Fig. 3A](#F3){ref-type="fig"}). The heterogeneity was significant but its magnitude was acceptable (*P* = 0.070, I^2^ = 57%, [Fig. 3A](#F3){ref-type="fig"}). However, the overall quality of the result was rated as low, due to the serious study limitation and serious imprecision ([Table 3](#T3){ref-type="table"}). From the subgroup analysis, we noticed only the efficacy of Spinomed was significant (*P* \< 0.001, [Fig. 3A](#F3){ref-type="fig"}); and so was the difference between subgroups (*P* = 0.030, [Fig. 3A](#F3){ref-type="fig"}).

![Forest plot. Comparison between brace group and no brace group. Use of brace showed significant efficacy on pain (**A**), kyphosis angle correction (**B**), and quality of life (**C**).](jkms-31-1641-g003){#F3}

###### Summary of findings (SOF) table of brace vs. no brace

![](jkms-31-1641-i003)

  Outcomes                         Anticipated absolute effects (95% CI)       No. of participants (studies)   Overall quality of evidence (GRADE)
  -------------------------------- ------------------------------------------- ------------------------------- -------------------------------------
  Pain reduction-pooled data       SMD 1.1 fewer (1.61 fewer to 0.59 fewer)    212 (3 studies)                 ⨁⨁◯◯
  LOW^\*,†^                                                                                                    
  Pain reduction-TLSO              SMD 0.57 fewer (1.48 fewer to 0.34 more)    23 (1 study)                    ⨁◯◯◯
  VERY LOW^‡,§^                                                                                                
  Pain reduction-soft brace        SMD 0.37 fewer (1.31 fewer to 0.57 more)    19 (1 study)                    ⨁◯◯◯
  VERY LOW^‡,§^                                                                                                
  Pain reduction-Spinomed group    SMD 1.46 fewer (1.81 fewer to 1.11 fewer)   170 (2 studies)                 ⨁⨁◯◯
  LOW^∥,†^                                                                                                     
  Kyphosis angle-pooled data       SMD 0.91 fewer (1.21 fewer to 0.61 fewer)   209 (3 studies)                 ⨁⨁◯◯
  LOW^¶,†^                                                                                                     
  Kyphosis angle-TLSO              SMD 0.72 fewer (1.69 fewer to 0.26 more)    21 (1 study)                    ⨁◯◯◯
  VERY LOW^\*\*,§^                                                                                             
  Kyphosis angle-soft brace        SMD 0.38 fewer (1.42 fewer to 0.66 more)    18 (1 study)                    ⨁◯◯◯
  VERY LOW^\*\*,§^                                                                                             
  Kyphosis angle-Spinomed group    SMD 0.99 fewer (1.32 fewer to 0.65 fewer)   170 (2 studies)                 ⨁⨁◯◯
  LOW^†,††^                                                                                                    
  Quality of life-pooled data      SMD 1.24 fewer (2.1 fewer to 0.38 fewer)    212 (3 studies)                 ⨁◯◯◯
  VERY LOW^\*,†,††^                                                                                            
  Quality of life-TLSO             SMD 0.49 fewer (1.39 fewer to 0.41 more)    23 (1 study)                    ⨁◯◯◯
  VERY LOW^‡,§^                                                                                                
  Quality of life-soft brace       SMD 0.2 fewer (1.13 fewer to 0.07 more)     19 (1 study)                    ⨁◯◯◯
  VERY LOW^‡,§^                                                                                                
  Quality of life-Spinomed brace   SMD 1.96 fewer (2.34 fewer to 1.58 fewer)   170 (2 studies)                 ⨁⨁◯◯
  LOW^∥,†^                                                                                                     

CIs, confidence intervals; SMD, standardized mean difference; RCT, randomized controlled trial; TLSO, thoracolumbar sacral orthosis.

^\*^Serious study limitation: three trials were included, with high risk of performance bias and detection bias; ^†^Serious imprecision: sample size was smaller than 400; ^‡^Serious study limitation: one trial was included, with high risk of detection bias and performance bias; ^§^Very serious imprecision: sample size was too small and CIs was wide; ^∥^Serious study limitation: two trials were included, with high risk of performance bias and detection bias; ^¶^Serious study limitation: three trials were included, with high risk of performance bias; ^\*\*^Serious study limitation: one trial was included, with high risk of performance bias; ^††^Serious study limitation: two trials were included, with high risk of performance bias; ^‡‡^Very serious inconsistency: the statistical heterogeneity was large (I^2^ \> 80%) and the clinical heterogeneity existed.

In the outcome of kyphosis angle, pooled data was similar to that of pain: the efficacy brought by brace was large and significant (SMD, -0.91; 95% CIs, -1.21 to -0.61; *P* \< 0.001, [Fig. 3B](#F3){ref-type="fig"}). Still, the overall quality of this evidence was rated as low for the serious study limitation and serious imprecision ([Table 3](#T3){ref-type="table"}). The difference between subgroups was insignificant (*P* = 0.510, [Fig. 3B](#F3){ref-type="fig"}), though only the Spinomed orthosis showed significant efficacy ([Fig. 3B](#F3){ref-type="fig"}). The consistency between subgroups might be a result of the similarity in their effect sizes and the relatively well overlapped CIs ([Fig. 3B](#F3){ref-type="fig"}).

Very low quality evidence indicated large and significant beneficial effect on quality of life brought by bracing (SMD, -1.24; 95% CIs, -2.10 to -0.38; *P* = 0.005, [Fig. 3C](#F3){ref-type="fig"}). The heterogeneity and the difference between subgroups were significant (*P* \< 0.001, [Fig. 3C](#F3){ref-type="fig"}). The large magnitude of I^2^ and the existence of clinical heterogeneity suggested downgrading 2 scores for the inconsistency ([Fig. 3](#F3){ref-type="fig"}). Thus, quality of this evidence was rated as very low, due to the serious study limitation, serious imprecision and the very serious inconsistency ([Table 3](#T3){ref-type="table"}). The untrustworthy of this outcome was also reflected by the result of sensitivity analysis, in which the pooled outcome changed to insignificant after excluding one of the two trials that had unclear risk of reporting bias ([@B11]) ([Fig. 4](#F4){ref-type="fig"}).

![Result of the sensitivity analysis of excluding one of the two trials with unclear risk of reporting bias. The outcome of quality of life became insignificant after excluding data of Pfeifer et al., 2004 (**A**→**B**).](jkms-31-1641-g004){#F4}

Analysis that compared soft brace with un-soft brace included two RCTs whose participants had acute vertebral fractures ([@B10][@B14]). The pooled data showed un-soft brace had no significant difference compared with soft brace ([Fig. 5](#F5){ref-type="fig"}). The result was different from the one previously observed, in which Spinomed brace showed significantly better efficacy compared to soft brace ([Fig. 3](#F3){ref-type="fig"}). The quality of evidence of pooled data was rated as very low in all outcomes, due to the serious study limitation and very serious imprecision ([Table 4](#T4){ref-type="table"}).

![Forest plot. Comparison between un-soft brace group and soft brace group. The results showed no significant difference between braces in pain (**A**), kyphosis angle (**B**) and quality of life (**C**).](jkms-31-1641-g005){#F5}

###### Summary of findings (SOF) table of un-soft brace vs. soft brace

![](jkms-31-1641-i004)

  Outcomes                           Anticipated absolute effects (95% CIs)     No. of participants (studies)   Overall quality of evidence (GRADE)
  ---------------------------------- ------------------------------------------ ------------------------------- -------------------------------------
  Pain reduction-pooled data         SMD 0.38 fewer (0.83 fewer to 0.07 more)   79 (2 studies)                  ⊕◯◯◯
  VERY LOW^\*,†,‡^                                                                                              
  Pain reduction-TLSO                SMD 0.31 fewer (1.06 fewer to 0.44 more)   28 (1 study)                    ⊕◯◯◯
  VERY LOW^§,∥^                                                                                                 
  Pain reduction-Spinomed orthosis   SMD 0.42 fewer (0.97 fewer to 0.14 more)   51 (1 study)                    ⊕⊕◯◯
  LOW^¶,‡^                                                                                                      
  Kyphosis angle-pooled data         SMD 0.19 fewer (0.83 fewer to 1.2 more)    38 (2 studies)                  ⊕◯◯◯
  VERY LOW^\*\*,†,∥^                                                                                            
  Kyphosis angle-TLSO                SMD 0.2 fewer (0.95 fewer to 0.54 more)    28 (1 study)                    ⊕◯◯◯
  VERY LOW^††,∥^                                                                                                
  Kyphosis angle-Spinomed orthosis   SMD 0.88 more (0.46 fewer to 2.21 more)    10 (1 study)                    ⊕◯◯◯
  VERY LOW^‡‡,∥^                                                                                                
  Quality of life-pooled data        SMD 0.25 fewer (0.69 fewer to 0.02 more)   79 (2 studies)                  ⊕◯◯◯
  VERY LOW^\*,†,‡^                                                                                              
  Quality of life-TLSO               SMD 0.33 fewer (1.08 fewer to 0.43 more)   28 (1 study)                    ⊕◯◯◯
  VERY LOW^§,∥^                                                                                                 
  Quality of life-Spinomed brace     SMD 0.21 fewer (0.76 fewer to 0.34 more)   51 (1 study)                    ⊕⊕◯◯
  LOW^¶,‡^                                                                                                      

CIs, confidence intervals; SMD, standardized mean difference; RCT, randomized controlled trial; TLSO, thoracolumbar sacral orthosis.

^\*^Serious study limitation: two trials were included, with high risk of performance bias and detection bias; ^†^Serious inconsistency: measurement time was different between studies; ^‡^Serious imprecision: sample size was smaller than 400; ^§^Serious study limitation: one study was included, with high risk of performance bias and detection bias; ^∥^Very serious imprecision: sample size was too small and CIs was wide; ^¶^Serious study limitation: one study was included, with high risk of performance and detection bias; ^\*\*^Serious study limitation: two trials were included, with high risk of performing bias; ^††^Serious study limitation: one study was included, with high risk of performance bias; ^‡‡^Serious study limitation: one study was included, with high risk of performance and unclear risk of selection bias.

Results from narrative analysis
-------------------------------

The narrative results were summarized in [Table 2](#T2){ref-type="table"}. Though most of the results showed benefits from using brace, the strength of them was relatively weak. Two RCTs had limitations in their methodologies: one had high risk of bias ([@B13]) and the other one had a small sample size ([@B15]). Also, we had limited confidence in conclusions of observational studies, because they might lack the power of proving causal relationship between the utilization of orthoses and the benefit.

Publication bias
----------------

The publication bias cannot be detected through the funnel plot because the number of trials included in our meta-analysis was less than 10.

DISCUSSION
==========

We included 10 trials in this study and 4 RCTs in meta-analysis. All trials had high risk of performance bias and most of them had unclear risk of selection bias. Low to very low quality evidence proved that using brace was effective in reducing pain, preventing kyphosis angle deterioration and improving quality of life. However, as observed in the subgroup analyses, only middle term use of Spinomed orthosis could bring significant improvement to the patients who had subacute fractures. Very low quality evidence indicated there was no significant difference between the efficacy of TLSO, Spinomed and soft brace, when they were implemented to the patients with acute fractures.

The pooled results were difficult to interpret and were relatively unreliable due to the limited information. Therefore, rather than solving the prescribe questions, current evidence might be more proper to find possible explanations or patterns of the efficacy. The result showed Spinomed orthosis could bring large and significant beneficial effects to patients with sub-acute fracture, but it was relatively unreliable because of the interference from chance and the limited detective ability in our study. Nevertheless, it also might be a result of the special mechanism of this brace. Unlike most of the braces that offer immobilization to the fracture site, the Spinomed orthosis worked with a concept of improving the strength of users\' trunk muscle. The stronger muscle of the users might subsequently reduce their pain and kyphosis angle deterioration, and improve their quality of life ([@B12]).

TLSO is one of the most widely used braces and should have shown beneficial effects in trials, but there was little evidence proving it in our study. The main reason for this contradiction should be the limited detective ability of our study. Other reasons might include the inadequate immobilization and the poor compliance of the brace ([@B13][@B18]). The inadequate immobilization might cause by the skin and soft tissues lie between orthosis and skeletal ([@B6]); while the poor compliance might cause by inappropriate implementation of the brace or complications like skin ulceration ([@B6]).

We noticed improvement in a single outcome cannot guarantee the improvements in others. Some equipment could reduce the kyphosis angle by exerting backward force to shoulders and forward force in thoracic region. But their efficacy in deformity was not always associated with improvement in mobility or quality of life ([@B16][@B20]). Also, the significant improvement in back muscle strength does not always accompany with relief of pain or improvement in physical function ([@B16]).

Two reviews investigated the subject recently, which had minor differences with ours. Newman et al. included osteoporosis and osteopenia participants and stated a descriptive review ([@B3]). Compared with theirs, our study focused on patients with OVF and conducted statistical analysis, which should bring more direct conclusions. Rzewuska et al. ([@B4]) investigated the efficacy of conservative treatments to OVF patients and included 3 RCTs about orthoses. Compared with them, we included 1 more trial that investigated the efficacy of rigid and soft braces. Also, we had different conclusions in the outcome of functional independence, while ours was more consistent with that of original article ([@B10]). Additionally, we analyzed the outcome of kyphosis angle, which was another critical parameter related to OVF patients. Excluding those differences, our results all revealed the need for high quality clinical trials.

There are several limitations in this study. The existence of publication bias might be covered by the absence of ongoing studies, grey literatures and trials from regional databases. The estimation of the treatment efficacy might be influenced by the language restriction in our inclusion criteria. The generalizability of results might be diminished by our relatively stringent criteria for evaluating the quality of evidence. Besides them, the biggest limitations were the limited number of included trials and the inconsistency between studies. All the limitations raised the difficulty in interpreting the results to some extent and fairly lowered the quality of evidence.

To obtain more dependable evidence, more RCTs with low risk of bias and big sample size are needed. Authors could lower the risk of selection bias through adequate description of the random sequence generation and allocation concealment. A cross-over study might be a proper design to minimize the risk of performance bias, since it might be inevitable for a trial about orthoses ([@B12]).

In conclusion, it might be appropriate to recommend middle term use of Spinomed orthoses to patients with subacute fractures. The evidence that could prove the efficacy of other brace was insufficient.

**Funding:** This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2061858).

**DISCLOSURE:** The authors have no potential conflicts of interest to disclose.

**AUTHOR CONTRIBUTION:** Study conception and design: Lee JH. Data acquisition: Jin YZ. Data analysis, interpretation: Jin YZ, Lee JH. Writing manuscript: Jin YZ, Lee JH. Revision: all authors. Approval of final manuscript: all authors.

Supplementary Materials
=======================

###### Supplementary 1

Search strategy for MEDLINE (via PubMed)

###### Supplementary 2

Rationales for the judgement of the risk of bias
